VERACYTE INC (VCYT) Fundamental Analysis & Valuation

NASDAQ:VCYT • US92337F1075

Current stock price

32.67 USD
+0.52 (+1.62%)
At close:
32.5 USD
-0.17 (-0.52%)
After Hours:

This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. VCYT Profitability Analysis

1.1 Basic Checks

  • In the past year VCYT was profitable.
  • In the past year VCYT had a positive cash flow from operations.
  • In multiple years VCYT reported negative net income over the last 5 years.
  • VCYT had a positive operating cash flow in 4 of the past 5 years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • The Return On Assets of VCYT (4.72%) is better than 90.72% of its industry peers.
  • With an excellent Return On Equity value of 5.07%, VCYT belongs to the best of the industry, outperforming 90.72% of the companies in the same industry.
  • The Return On Invested Capital of VCYT (4.59%) is better than 90.33% of its industry peers.
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROIC 4.59%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • VCYT has a Profit Margin of 12.83%. This is amongst the best in the industry. VCYT outperforms 91.68% of its industry peers.
  • The Operating Margin of VCYT (15.14%) is better than 92.07% of its industry peers.
  • Looking at the Gross Margin, with a value of 70.10%, VCYT belongs to the top of the industry, outperforming 80.27% of the companies in the same industry.
  • VCYT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. VCYT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
  • Compared to 1 year ago, VCYT has more shares outstanding
  • Compared to 5 years ago, VCYT has more shares outstanding
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • An Altman-Z score of 16.69 indicates that VCYT is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of VCYT (16.69) is better than 86.07% of its industry peers.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.69
ROIC/WACC0.5
WACC9.21%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • VCYT has a Current Ratio of 8.15. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 8.15, VCYT is in the better half of the industry, outperforming 72.15% of the companies in the same industry.
  • VCYT has a Quick Ratio of 7.81. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 7.81, VCYT is in the better half of the industry, outperforming 70.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 7.81
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. VCYT Growth Analysis

3.1 Past

  • VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 176.67%, which is quite impressive.
  • The Revenue has grown by 16.01% in the past year. This is quite good.
  • The Revenue has been growing by 34.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%

3.2 Future

  • Based on estimates for the next years, VCYT will show a very strong growth in Earnings Per Share. The EPS will grow by 21.22% on average per year.
  • VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.74% yearly.
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue Next Year13.07%
Revenue Next 2Y12.7%
Revenue Next 3Y11.91%
Revenue Next 5Y10.74%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. VCYT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 39.36, VCYT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.10% of the companies listed in the same industry.
  • VCYT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.91.
  • VCYT is valuated quite expensively with a Price/Forward Earnings ratio of 28.24.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 92.65% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, VCYT is valued at the same level.
Industry RankSector Rank
PE 39.36
Fwd PE 28.24
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaply inside the industry as 92.46% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, VCYT is valued cheaply inside the industry as 95.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.5
EV/EBITDA 21.39
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of VCYT may justify a higher PE ratio.
  • A more expensive valuation may be justified as VCYT's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y26.95%
EPS Next 3Y26.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VCYT Dividend Analysis

5.1 Amount

  • VCYT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VCYT Fundamentals: All Metrics, Ratios and Statistics

VERACYTE INC

NASDAQ:VCYT (4/8/2026, 8:08:10 PM)

After market: 32.5 -0.17 (-0.52%)

32.67

+0.52 (+1.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners110.45%
Inst Owner Change0%
Ins Owners0.42%
Ins Owner Change6.44%
Market Cap2.60B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target49.52 (51.58%)
Short Float %6.84%
Short Ratio5.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)-1.29%
PT rev (3m)0.38%
EPS NQ rev (1m)-12.75%
EPS NQ rev (3m)-21.3%
EPS NY rev (1m)0%
EPS NY rev (3m)9.96%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)2.43%
Valuation
Industry RankSector Rank
PE 39.36
Fwd PE 28.24
P/S 5.02
P/FCF 20.5
P/OCF 19.04
P/B 1.98
P/tB 5.73
EV/EBITDA 21.39
EPS(TTM)0.83
EY2.54%
EPS(NY)1.16
Fwd EY3.54%
FCF(TTM)1.59
FCFY4.88%
OCF(TTM)1.72
OCFY5.25%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)1
PEG (5Y)N/A
Graham Number17.54
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROCE 5.82%
ROIC 4.59%
ROICexc 6.63%
ROICexgc 80.43%
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
FCFM 24.49%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.19%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 136.72%
Profit Quality 190.84%
Current Ratio 8.15
Quick Ratio 7.81
Altman-Z 16.69
F-Score8
WACC9.21%
ROIC/WACC0.5
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year13.07%
Revenue Next 2Y12.7%
Revenue Next 3Y11.91%
Revenue Next 5Y10.74%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.84%
EBIT Next 3Y58.94%
EBIT Next 5Y37.52%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A

VERACYTE INC / VCYT Fundamental Analysis FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


Can you provide the profitability details for VERACYTE INC?

VERACYTE INC (VCYT) has a profitability rating of 7 / 10.


Can you provide the financial health for VCYT stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.